Shares of Pharming Group NV (OTCMKTS:PHGUF – Get Free Report) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.22 and traded as low as $1.1050. Pharming Group shares last traded at $1.1050, with a volume of 1,000 shares traded.
Pharming Group Price Performance
The company has a quick ratio of 2.31, a current ratio of 3.01 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $741.53 million, a price-to-earnings ratio of 92.08 and a beta of 0.46. The business has a 50-day simple moving average of $1.22 and a two-hundred day simple moving average of $1.36.
Pharming Group Company Profile
Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.
Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.
Recommended Stories
- Five stocks we like better than Pharming Group
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
